Results for “”

Entry Author Date Location
New Bain Investor Yumin Choi on Obamacare’s Future, Surviving Cancer 01/09/17 Boston
Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M 01/08/17 Boston
PatientsLikeMe Nabs $100M, Works to Advance Personalized Medicine 01/06/17 Boston
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Bio Roundup: Biogen Price Fears, A Grail Billion, Hellos, Byes & More 01/06/17 National
Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug 01/06/17 National
Rethink Robotics Adds $18M to Funding Pot Amid Automation Debate 01/05/17 Boston
Bike-Sharing Firm Zagster Zooms Ahead With $10M Led by Edison 01/05/17 Boston
Jet.com Grabs ShoeBuy for $70M as Walmart Expands E-Commerce Arsenal 01/05/17 Boston
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines 01/05/17 Boston
Finally Gets $15M Jolt For New Take on Nikola Tesla Lightbulb Tech 01/04/17 Boston
Infinity Pharma R&D Chief Adams Retires Amid Restructuring, Job Cuts 01/04/17 Boston
Edico Genome’s Deal with Dell EMC Fits Partnership Strategy 01/04/17 San Diego
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
Boston Tech Agenda 2017: 5 Things to Watch For This Year 01/04/17 Boston
Inotek’s Glaucoma Drug Flunks in First Phase 3 Test, Shares Crumble 01/03/17 Boston
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech 12/30/16 New York
2016’s Last Boston Tech Watch: Akamai, Neurable, Facebook, GM & More 12/30/16 Boston
Gates Foundation Sends $140M to Intarcia for HIV Version of Pump 12/29/16 Boston
Military Families, Seniors in MA and IN to Test Major Healthcare Reform 12/29/16 Detroit Ann Arbor
Artificial Intelligence Startup Neurala Lands $13.7M in Funding 12/28/16 Boston
Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug 12/28/16 Boston
Top Stories of 2016 for Xconomy Boston: Editor’s Picks 12/26/16 Boston
Ionis, Biogen Make History With FDA Nod for Spine Disease Drug 12/23/16 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
VC Sizes Up Google As Consumer Electronics Challenger To Apple Et Al. 12/23/16 San Francisco
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Page 2 of 296 « previous page · next page »